Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7975)
All Articles published online
|
Publishing Process of This Article
|
Jul 19, 2021 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Onaolapo AY, Onaolapo OJ. Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule. World J Psychiatr 2021; 11(7): 297-315 [PMID: 34327123 DOI: 10.5498/wjp.v11.i7.297] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i7/297.htm |
| Number | Citing Articles |
| 1 |
Cyrus Su Hui Ho, Gabrielle Wann Nii Tay, Hai Ning Wee, Jianhong Ching. The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity. International Journal of Molecular Sciences 2023; 24(3): 2231 doi: 10.3390/ijms24032231
|
| 2 |
Amjad Mhanna, Nafiza Martini, Ghefar Hmaydoosh, George Hamwi, Mulham Jarjanazi, Ghaith Zaifah, Reem Kazzazo, Aya Haji Mohamad, Zuheir Alshehabi. The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review. Medicine 2024; 103(5): e37114 doi: 10.1097/MD.0000000000037114
|
| 3 |
Benjamin F. Gruenbaum, Alexander Zlotnik, Anna Oleshko, Frederic Matalon, Honore N. Shiyntum, Amit Frenkel, Matthew Boyko. The Relationship between Post-Traumatic Stress Disorder Due to Brain Injury and Glutamate Intake: A Systematic Review. Nutrients 2024; 16(6): 901 doi: 10.3390/nu16060901
|
| 4 |
Douglas F. Watt. The separation distress hypothesis of depression – an update and systematic review. Neuropsychoanalysis 2023; 25(2): 103 doi: 10.1080/15294145.2023.2240340
|
| 5 |
Essia Hamdi, Slah Hidouri, Ana-Belén Muniz-Gonzalez, Alberto Marcos Bermejo, César Venero, Salem Amara, Ahmed Landoulsi. The role of glutamic acid-modified silica nanoparticles in promoting brain health. Advances in Redox Research 2024; 10: 100095 doi: 10.1016/j.arres.2024.100095
|
| 6 |
Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo. Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the
Microbiota Become a Viable Therapeutic Strategy?. CNS & Neurological Disorders - Drug Targets 2023; 22(9): 1355 doi: 10.2174/1871527321666220903114559
|
| 7 |
Yali Weng, Yu Zhang, Yinhan Li, Xinpei Lin, Zhenkun Guo, Hong Hu, Wenya Shao, Guangxia Yu, Fuli Zheng, Ping Cai, Huangyuan Li, Siying Wu. Single-cell RNA-sequencing of cellular heterogeneity and pathogenic mechanisms in paraquat-induced Parkinson's disease with depression. Ecotoxicology and Environmental Safety 2024; 273: 116169 doi: 10.1016/j.ecoenv.2024.116169
|
| 8 |
Evgenii Gusev, Alexey Sarapultsev. Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory
Model of Chronic Stress and Depression: A Narrative Review. Current Pharmaceutical Design 2024; 30(3): 180 doi: 10.2174/0113816128285578231218102020
|
| 9 |
Dania Akbar, Taeho Greg Rhee, Felicia Ceban, Roger Ho, Kayla M. Teopiz, Bing Cao, Mehala Subramaniapillai, Angela T. H. Kwan, Joshua D. Rosenblat, Roger S. McIntyre. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials. CNS Drugs 2023; 37(10): 867 doi: 10.1007/s40263-023-01032-5
|
| 10 |
Sebastian Reyes-Lizaola, Ulises Luna-Zarate, Hiram Tendilla-Beltrán, Julio César Morales-Medina, Gonzalo Flores. Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2024; 129: 110876 doi: 10.1016/j.pnpbp.2023.110876
|
| 11 |
Shu Wang, Yu-Guang Guan, Yan-Hua Zhu, Min-Zhong Wang. Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective. World Journal of Psychiatry 2022; 12(6): 779-786 doi: 10.5498/wjp.v12.i6.779
|
| 12 |
Yara S. Abdelkawy, Mona Elharoun, Eman Sheta, Ihab Talat Abdel-Raheem, Hisham A. Nematalla. Liraglutide and Naringenin relieve depressive symptoms in mice by enhancing Neurogenesis and reducing inflammation. European Journal of Pharmacology 2024; 971: 176525 doi: 10.1016/j.ejphar.2024.176525
|
| 13 |
O. K. Savushkina, I. S. Boksha, M. A. Omelchenko, E. B. Tereshkina, T. A. Prokhorova, E. A. Vorobyeva, G. Sh. Burbaeva. Correlations between biochemical and clinical parameters in patients at risk for schizophrenia spectrum disorders. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery) 2023; (3): 213 doi: 10.33920/med-01-2303-06
|
| 14 |
Adejoke Y. Onaolapo, Olakunle J. Onaolapo. Natural Molecules in Neuroprotection and Neurotoxicity. 2024; : 1263 doi: 10.1016/B978-0-443-23763-8.00026-9
|
| 15 |
O.K. Savushkina, I.S. Boksha, M.A. Omel’chenko, E.B. Tereshkina, T.A. Prokhorova, E.A. Vorobieva, G.Sh. Burbaeva. Activity of enzymes of glutamate, energy and glutathione metabolism in the first juvenile depression with attenuated symptoms of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2022; 122(8): 136 doi: 10.17116/jnevro2022122081136
|
| 16 |
Amir Saeed, Talal Alharazi, Khalid Alshaghdali, Raja Rezgui, Ibtihag Elnaem, Bunder Albdullah T. Alreshidi, Munazzah Tasleem, Mohd Saeed, Rekha Khandia. Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects. Journal of Alzheimer's Disease 2024; 97(3): 1299 doi: 10.3233/JAD-230821
|
| 17 |
Thanasis Mitsis, Eleni Papakonstantinou, Dimitrios Vlachakis. Biological mechanisms underlying depression, epigenetics and their interplay (Review). International Journal of Epigenetics 2023; 3(1) doi: 10.3892/ije.2023.17
|
| 18 |
Gita Kholghi, Shirin Arjmandi-Rad, Mohammad-Reza Zarrindast, Salar Vaseghi. St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(6): 629 doi: 10.1007/s00210-022-02229-z
|
| 19 |
Matthew Boyko, Benjamin F. Gruenbaum, Anna Oleshko, Igor Merzlikin, Alexander Zlotnik. Diet’s Impact on Post-Traumatic Brain Injury Depression: Exploring Neurodegeneration, Chronic Blood–Brain Barrier Destruction, and Glutamate Neurotoxicity Mechanisms. Nutrients 2023; 15(21): 4681 doi: 10.3390/nu15214681
|
| 20 |
Benjamin Fredrick Gruenbaum, Alexander Zlotnik, Amit Frenkel, Ilya Fleidervish, Matthew Boyko. Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System. Metabolites 2022; 12(5): 459 doi: 10.3390/metabo12050459
|
| 21 |
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, Francesco Benedetti. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs 2022; 36(7): 681 doi: 10.1007/s40263-022-00931-3
|
| 22 |
Catalina Torres Soler, Sofia H. Kanders, Mattias Rehn, Susanne Olofsdotter, Cecilia Åslund, Kent W. Nilsson. A Three-Way Interaction of Sex, PER2 rs56013859 Polymorphism, and Family Maltreatment in Depressive Symptoms in Adolescents. Genes 2023; 14(9): 1723 doi: 10.3390/genes14091723
|